Chi‐Kuan Chen
Impact in
-
- MicroRNA in disease regulation
- Reproductive Medicine top 10%
Papers in
-
- Cancer-related gene regulation 4
- RNA modifications and cancer 3
- Epigenetics and DNA Methylation 3
- Oncology 12
- Viral-associated cancers and disorders 3
- HER2/EGFR in Cancer Research 3
- Co-authors
- Shih‐Wei Chen (1 shared paper)An‐Shik Yang (2 shared papers)Hsin‐Yi Lee (1 shared paper)Mu‐Hsien Yu (1 shared paper)Her‐Young Su (1 shared paper)Wea‐Lung Lin (2 shared papers)Hung‐Cheng Lai (1 shared paper)Ya‐Wen Lin (1 shared paper)
- Journals
- Oncotarget (2 papers)Energy & Fuels (2 papers)Journal of Cutaneous Pathology (1 paper)Journal of Cellular Physiology (1 paper)Human Pathology (1 paper)
- Partner nations
- TaiwanUnited StatesRussia
In The Last Decade
Chi‐Kuan Chen
39 papers receiving 995 citations
Peers
Comparison fields: 5 of 97
- Cancer Research 149
- Reproductive Medicine 65
- Health, Toxicology and Mutagenesis 97
- Molecular Biology 462
- Oncology 173
Countries citing papers authored by Chi‐Kuan Chen
This map shows the geographic impact of Chi‐Kuan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Kuan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Kuan Chen more than expected).
Fields of papers citing papers by Chi‐Kuan Chen
This network shows the impact of papers produced by Chi‐Kuan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Kuan Chen. The network helps show where Chi‐Kuan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi‐Kuan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 154 | |
| 2 | 2014 | 145 | |
| 3 | 2014 | 130 | |
| 4 | 2016 | 111 | |
| 5 | 2006 | 98 | |
| 6 | 2018 | 49 | |
| 7 | 2008 | 36 | |
| 8 | 2016 | 28 | |
| 9 | 2006 | 23 | |
| 10 | 2013 | 23 | |
| 11 | 2013 | 20 | |
| 12 | 2018 | 19 | |
| 13 | 2015 | 17 | |
| 14 | 2008 | 16 | |
| 15 | 2017 | 16 | |
| 16 | 2013 | 16 | |
| 17 | 2009 | 14 | |
| 18 | 2014 | 10 | |
| 19 | 2010 | 8 | |
| 20 | 2010 | 8 |
About Chi‐Kuan Chen
Chi‐Kuan Chen is a scholar working on Molecular Biology, Oncology, Surgery, Pathology and Forensic Medicine and Neurology, having authored 40 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (4 papers), Cancer-related gene regulation (4 papers), Viral-associated cancers and disorders (3 papers), HER2/EGFR in Cancer Research (3 papers), RNA modifications and cancer (3 papers), Epigenetics and DNA Methylation (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Cutaneous lymphoproliferative disorders research (3 papers). The work is most often cited by research in Cancer Research (149 citations), Reproductive Medicine (65 citations), Health, Toxicology and Mutagenesis (97 citations), Molecular Biology (462 citations) and Oncology (173 citations). Chi‐Kuan Chen has collaborated with scholars based in Taiwan, United States and Russia. Frequent co-authors include Shih‐Wei Chen, An‐Shik Yang, Hsin‐Yi Lee, Mu‐Hsien Yu, Her‐Young Su, Wea‐Lung Lin, Hung‐Cheng Lai, Ya‐Wen Lin, Yu‐Ching Chou and Wen‐Chi Lin. Their work appears in journals such as Oncotarget, Energy & Fuels, Journal of Cutaneous Pathology, Journal of Cellular Physiology and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.